Nektar Therapeutics pain drug for knee arthritis fails study

by admin on September 26, 2013

(Reuters) – Nektar Therapeutics said its experimental drug to treat chronic pain in patients with arthritis of the knee failed to meet its main goal in a mid-stage clinical trial. The drugmaker's shares fell nearly 30 percent in extended trading on Thursday. The study failed mainly because patients on placebo did not show the expected increase in pain scores observed in similar studies, Nektar …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: